Applied Genetic Technologies Corp AGTC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
3.40quote price arrow down-0.03 (-0.87%)
Volume
58,706
Close
3.43quote price arrow up+0.09 (+2.69%)
Volume
356,516
52 week range
3.12 - 9.67
Loading...
  • Open3.30
  • Day High3.45
  • Day Low3.28
  • Prev Close3.34
  • 52 Week High9.67
  • 52 Week High Date02/17/21
  • 52 Week Low3.12
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap146.63M
  • Shares Out42.75M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta2.13
  • YTD % Change-16.14

KEY STATS

  • Open3.30
  • Day High3.45
  • Day Low3.28
  • Prev Close3.34
  • 52 Week High9.67
  • 52 Week High Date02/17/21
  • 52 Week Low3.12
  • 52 Week Low Date08/20/21
  • Market Cap146.63M
  • Shares Out42.75M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta2.13
  • YTD % Change-16.14

RATIOS/PROFITABILITY

  • EPS (TTM)-2.16
  • P/E (TTM)-1.59
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-56.33M
  • ROE (MRQ)-66.22%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,023.20%
  • Debt To Equity (MRQ)10.29%

EVENTS

  • Earnings Date09/20/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Applied Genetic Technologies Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic therapies for patients suffering from rare and debilitating diseases. Its focus is in the field of ophthalmology where it has active clinical programs in X-linked retinitis pigmentosa (XLRP), achromatopsia (ACHM), and optogenetics. The Company has approximately one preclinical program in otology and three preclinical programs targeting...
Scott Koenig M.D., Ph.D.
Chairman
Susan Washer
President
Jerry Reynolds
Chief Accounting Officer
Matthew Feinsod M.D.
Executive Vice President
Stephen Potter
Vice President
Address
14193 Nw 119Th Terrace, Suite #10
Alachua, FL
32615
United States

Top Peers

SYMBOLLASTCHG%CHG
ELOX
Eloxx Pharmaceuticals Inc
1.87+0.12+6.86%
GNPX
Genprex Inc
2.85+0.13+4.78%
LTRN
Lantern Pharma Inc.
11.83-0.46-3.74%
PYPD
PolyPid Ltd
7.78+0.17+2.23%
SIOX
Sio Gene Therapies Inc
2.22-0.02-0.89%